Discovery of a novel small molecule inhibitor of the YAP1/TAZ-TEAD transcriptional complex

被引：0
|
作者：
Moure, Casey J. [1 ]
Sondey, Christopher [1 ]
Cheng, Mangeng [1 ]
Mansueto, My [1 ]
Fernandez, Rafael [1 ]
Schneider, Sebastian E. [1 ]
Ramirez, Julia V. [1 ]
Long, Brian [1 ]
DiMauro, Erin [1 ]
Vara, Brandon [1 ]
Yeung, Charles [1 ]
Achab, Abe [1 ]
Lim, Jongwon [1 ]
Kim, Ronald [1 ]
Zarate, Cayetana [1 ]
Bennett, Jonathan [1 ]
Palte, Rachel [1 ]
Foti, Robert [1 ]
Simov, Vladimir [1 ]
Barry, Evan [1 ]
机构：
[1] Merck Sharp & Dohme Ltd, Boston, MA USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3938
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A covalent inhibitor of the YAP-TEAD transcriptional complex identified by high-throughput screening
    Nutsch, Kayla
    Song, Lirui
    Chen, Emily
    Hull, Mitchell
    Chatterjee, Arnab K.
    Chen, Jian Jeffery
    Bollong, Michael J.
    RSC CHEMICAL BIOLOGY, 2023, : 894 - 905
  • [32] YAP1 and TAZ mediate BET inhibitor-dependent immune regulation in NSCLC.
    Reggiani, Francesca
    Gobbi, Giulia
    Lococo, Filippo
    Paci, Massimiliano
    Zznetti, Eleonora
    Piana, Simonetta
    Ciarrocchi, Alessia
    Sancisi, Valentina
    MOLECULAR CANCER RESEARCH, 2020, 18 (08) : 50 - 51
  • [33] TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors
    Edwards, A. Cole
    Stalnecker, Clint A.
    Morales, Alexis Jean
    Taylor, Khalilah E.
    Klomp, Jennifer E.
    Klomp, Jeffrey A.
    Waters, Andrew M.
    Sudhakar, Niranjan
    Hallin, Jill
    Tang, Tracy T.
    Olson, Peter
    Post, Leonard
    Christensen, James G.
    Cox, Adrienne D.
    Der, Channing J.
    CANCER RESEARCH, 2023, 83 (24) : 4112 - 4129
  • [34] Targeting the Hippo-YAP pathway with novel small-molecule inhibitors of the YAP-TEAD transcription activity
    Tang, Tracy T.
    Konradi, Andrei W.
    Feng, Ying
    Peng, Xiao
    Qiao, Sofie
    Post, Leonard
    CANCER RESEARCH, 2019, 79 (13)
  • [35] TEAD inhibition overcomes YAP1/TAZ-driven resistance to RAS inhibitors in KRASG12C-mutant cancers
    Edwards, Alexander C.
    Stalnecker, Clint A.
    Morales, Alexis J.
    Taylor, Khalilah E.
    Hallin, Jill
    Olson, Peter
    Tang, Tracy T.
    Engstrom, Lars
    Post, Leonard
    Christensen, James G.
    Cox, Adrienne D.
    Der, Channing J.
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [36] YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis
    Kristian W. Pajtler
    Yiju Wei
    Konstantin Okonechnikov
    Patricia B. G. Silva
    Mikaella Vouri
    Lei Zhang
    Sebastian Brabetz
    Laura Sieber
    Melissa Gulley
    Monika Mauermann
    Tatjana Wedig
    Norman Mack
    Yuka Imamura Kawasawa
    Tanvi Sharma
    Marc Zuckermann
    Felipe Andreiuolo
    Eric Holland
    Kendra Maass
    Huiqin Körkel-Qu
    Hai-Kun Liu
    Felix Sahm
    David Capper
    Jens Bunt
    Linda J. Richards
    David T. W. Jones
    Andrey Korshunov
    Lukas Chavez
    Peter Lichter
    Mikio Hoshino
    Stefan M. Pfister
    Marcel Kool
    Wei Li
    Daisuke Kawauchi
    Nature Communications, 10
  • [37] YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis
    Pajtler, Kristian W.
    Wei, Yiju
    Okonechnikov, Konstantin
    Silva, Patricia B. G.
    Vouri, Mikaella
    Zhang, Lei
    Brabetz, Sebastian
    Sieber, Laura
    Gulley, Melissa
    Mauermann, Monika
    Wedig, Tatjana
    Mack, Norman
    Kawasawa, Yuka Imamura
    Sharma, Tanvi
    Zuckermann, Marc
    Andreiuolo, Felipe
    Holland, Eric
    Maass, Kendra
    Koerkel-Qu, Huiqin
    Liu, Hai-Kun
    Sahm, Felix
    Capper, David
    Bunt, Jens
    Richards, Linda J.
    Jones, David T. W.
    Korshunov, Andrey
    Chavez, Lukas
    Lichter, Peter
    Hoshino, Mikio
    Pfister, Stefan M.
    Kool, Marcel
    Li, Wei
    Kawauchi, Daisuke
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [38] YAP1 SUBGROUP SUPRATENTORIAL EPENDYMOMA REQUIRES TEAD AND NUCLEAR FACTOR I-MEDIATED TRANSCRIPTIONAL PROGRAMS FOR TUMORIGENESIS
    Pajtler, Kristian
    Wei, Yiju
    Okonechniov, Konstantin
    Vouri, Mikaella
    Sahm, Felix
    Bunt, Jens
    Jones, David
    Korshunov, Andrey
    Lichter, Peter
    Pfister, Stefan
    Kool, Marcel
    Li, Wei
    Kawauchi, Daisuke
    NEURO-ONCOLOGY, 2019, 21 : 78 - 78
  • [39] Loss of Mob1a/b in mice results in chondrodysplasia due to YAP1/TAZ-TEAD-dependent repression of SOX9
    Goto, Hiroki
    Nishio, Miki
    To, Yoko
    Oishi, Tatsuya
    Miyachi, Yosuke
    Maehama, Tomohiko
    Nishina, Hiroshi
    Akiyama, Haruhiko
    Mak, Tak Wah
    Makii, Yuma
    Saito, Taku
    Yasoda, Akihiro
    Tsumaki, Noriyuki
    Suzuki, Akira
    DEVELOPMENT, 2018, 145 (06):
  • [40] β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
    Rosenbluh, Joseph
    Nijhawan, Deepak
    Cox, Andrew G.
    Li, Xingnan
    Neal, James T.
    Schafer, Eric J.
    Zack, Travis I.
    Wang, Xiaoxing
    Tsherniak, Aviad
    Schinzel, Anna C.
    Shao, Diane D.
    Schumacher, Steven E.
    Weir, Barbara A.
    Vazquez, Francisca
    Cowley, Glenn S.
    Root, David E.
    Mesirov, Jill P.
    Beroukhim, Rameen
    Kuo, Calvin J.
    Goessling, Wolfram
    Hahn, William C.
    CELL, 2012, 151 (07) : 1457 - 1473
12345